We are live on
!
Find out more
PCM
Patient Capital Management Portfolio holdings
AUM
$2.74B
1-Year Est. Return
43.59%
This Fund
S&P 500
This Quarter
Est. Return
-1.3%
1 Year Est. Return
+43.59%
3 Year Est. Return
+124.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.7B
AUM Growth
-$92.8M
(-5.2%)
Cap. Flow
-$38.9M
Cap. Flow
% of AUM
-2.28%
Top 10 Holdings %
Top 10 Hldgs %
46.62%
Holding
47
New
2
Increased
10
Reduced
25
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$42.9M |
| 2 |
Kosmos Energy
KOS
|
+$37.7M |
| 3 |
PPLI
People Inc
PPLI
|
+$34.6M |
| 4 |
DXC Technology
DXC
|
+$25.1M |
| 5 |
Citigroup
C
|
+$16.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$41.8M |
| 2 |
TMHC
Taylor Morrison
TMHC
|
+$29M |
| 3 |
Ovintiv
OVV
|
+$25.6M |
| 4 |
Uber
UBER
|
+$21.9M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 32.1% |
| 2 | Financials | 23.01% |
| 3 | Communication Services | 11.94% |
| 4 | Energy | 10.92% |
| 5 | Technology | 8.29% |
Similar funds
CIAS
LMIM
GC
CC
PA
XL
SFFS
HRCM
Patient Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Patient Capital Management held 47 positions worth $1.7B, down 5.2% from $1.8B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Patient Capital Management's Q3 2023 filing shows 2 new, 10 increased, 25 reduced and 5 closed positions. Its largest new stake was CVS Health: 605,120 shares worth $42.2M. The largest sale was Farfetch Limited Class A Ordinary Shares, an estimated $41.8M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 32% of assets, down from 34% a quarter earlier, followed by Financials and Communication Services.
- Patient Capital Management's largest Q3 2023 buy was CVS Health: 605,120 shares worth $42.2M.
- Patient Capital Management added most to People Inc in Q3 2023, an estimated $34.6M increase.
- Patient Capital Management's biggest Q3 2023 reduction was Ovintiv, cutting an estimated $25.6M.
- Patient Capital Management fully exited Farfetch Limited Class A Ordinary Shares in Q3 2023, selling an estimated $41.8M.
- Patient Capital Management's ten largest holdings make up 47% of its $1.7B portfolio in Q3 2023.
- Patient Capital Management opened 2 new positions and closed 5 in Q3 2023.
- Patient Capital Management's portfolio value fell 5.2% quarter-over-quarter to $1.7B.
Based on Patient Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.